A Randomized, Controlled, Observer-blind Psoriasis Plaque Test to Investigate the Anti-psoriatic Efficacy, Tolerability and Safety (Skin Atrophy) of LAS41004 Formulations in Patients With Mild to Moderate Plaque Psoriasis
Phase of Trial: Phase I/II
Latest Information Update: 18 Jul 2014
Price : $35 *
At a glance
- Drugs Betamethasone dipropionate/bexarotene (Primary) ; Bexarotene
- Indications Psoriasis
- Focus Pharmacokinetics
- Sponsors Almirall S.A.
- 06 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 23 Apr 2014 New trial record